16:55 EDT Fortress Biotech files to sell 6.19M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
16:55 EDT Fortress Biotech files to sell 6.19M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Elevai Labs (ELAB), 132% surge in interest Avidity Biosciences
Fortress Biotech entered into securities purchase agreements with healthcare focused institutional investors for the issuance and sale of 3,939,394 shares of its common stock in a registered direct offering at
MIAMI, Sept. 20, 2024 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress” or “Company”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty revenue, today announced that on September 19, 2024
Biologics License Application currently under review by U.S. FDA; PDUFA goal date of December 28, 2024 Biologics License Application currently under review by U.S. FDA; PDUFA goal date of December 28, 2024